(Q35890738)

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The indigenous gastrointestinal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Taxonomic Lactobacillus Composition of Feces from Human Newborns during the First Few Days

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

A model of host-microbial interactions in an open mammalian ecosystem

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Germ-free and colonized mice generate the same products from enteric prodefensins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Bacterial exposure induces and activates matrilysin in mucosal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Commensal host-bacterial relationships in the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Molecular analysis of commensal host-microbial relationships in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

A heat labile soluble factor from Bacteroides thetaiotaomicron VPI-5482 specifically increases the galactosylation pattern of HT29-MTX cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Epithelial cells as sensors for microbial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Defensins and innate host defence of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Intestinal epithelial-mesenchymal cell interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Development of the human gastrointestinal tract: twenty years of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The structure and regulation of tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Role of tight junctions in establishing and maintaining cell polarity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Regulation of the movement of solutes across tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Cellular microbiology emerging

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Host/pathogen interactions. Subversion of the mammalian cell cytoskeleton by invasive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Exploitation of mammalian host cell functions by bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Regulation of mucin exocytosis from intestinal goblet cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Signal transduction, packaging and secretion of mucins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Epithelial M cells: differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Collaboration of epithelial cells with organized mucosal lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

How the gut senses its content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Toll-like receptors in the induction of the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Epithelial antimicrobial peptides in host defense against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Innate immunity and the normal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial peptides in innate intestinal host defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial peptides of vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial proteins and peptides in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Epithelial antimicrobial peptides and proteins: their role in host defence and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial peptides as mediators of epithelial host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial peptides in mammalian and insect host defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial peptides in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Production of beta-defensin-2 by human colonic epithelial cells induced by Salmonella enteritidis flagella filament structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Salmonella enteritidis FliC (flagella filament protein) induces human beta-defensin-2 mRNA production by Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Resistance to host antimicrobial peptides is necessary for Salmonella virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Bacteriocin diversity: ecological and evolutionary perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Trypsin mediates growth phase-dependent transcriptional tegulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Variation in human intestinal microbiota with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactic acid bacteria in the gut in normal and disordered states

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Functional food science and gastrointestinal physiology and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotic agents and infectious diseases: a modern perspective on a traditional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Biotherapeutic agents in the treatment of infectious diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics: an overview of beneficial effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The place of probiotics in human intestinal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics in human infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics and Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Role played by lactobacilli in controlling the population of vaginal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus strains and vaginal ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Adhesion of Bifidobacterium spp. to human intestinal mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Purification and characterization of a surface protein from Lactobacillus fermentum 104R that binds to porcine small intestinal mucus and gastric mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Examination of adhesive determinants in three species of Lactobacillus isolated from chicken.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Identification and characterization of novel surface proteins in Lactobacillus johnsonii and Lactobacillus gasseri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Competition for adhesion between probiotics and human gastrointestinal pathogens in the presence of carbohydrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The Antimicrobial Properties of Different Strains of Lactobacillus spp. Isolated from Kefir

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Adhesive property of Bifidobacterium lactis LKM512 and predominant bacteria of intestinal microflora to human intestinal mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Use of Lactobacillus to prevent infection by pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactic acid bacteria as vaccine delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacilli as live vaccine delivery vectors: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Association of Lactobacillus spp. with Peyer's patches in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Inhibition of Bacterial Translocation from the Gastrointestinal Tract of Mice by Oral Administration of a Culture Condensate of Bifidobacterium longum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antagonistic activity of Lactobacillus casei strain shirota against gastrointestinal Listeria monocytogenes infection in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Safety of probiotics that contain lactobacilli or bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Survival of Lactobacillus species (strain GG) in human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus crispatus and its nonaggregating mutant in human colonization trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus GG in Prevention of Traveler's Diarrhea:An Encouraging First Step.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Prevention of travellers' diarrhoea by Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effect of antimicrobial agents on the ecological balance of human microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The role of probiotics in the treatment and prevention of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effects of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Potential role of lactobacilli as prophylactic agents against genital pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Control of the Microbial Flora of the Vagina by H202-Generating Lactobacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The Relationship of Hydrogen Peroxide-Producing Lactobacilli to Bacterial Vaginosis and Genital Microflora in Pregnant Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Inhibition of Neisseria gonorrhoeae by Lactobacillus species that are commonly isolated from the female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antagonistic effects of intestinal Lactobacillus isolates on pathogens of chicken

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics and immunity. Introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Interactions between the microbiota and the intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Nonlipopolysaccharide components) ofLactobacillus addophilusstimulate(s) the production of interleukin‐1α and tumor necrosis factor‐α by murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Proinflammatory cytokine and nitric oxide induction in murine macrophages by cell wall and cytoplasmic extracts of lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effects of lactic acid bacteria ingestion of basal cytokine mRNA and immunoglobulin levels in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effect of probiotic strains on interleukin 8 production by HT29/19A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Adhesion of lactic acid bacteria to caco-2 cells and their effect on cytokine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lipoteichoic acids from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Activation of human NK cells by staphylococci and lactobacilli requires cell contact-dependent costimulation by autologous monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Immunomodulatory function of lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Immunomodulation by treatment with Lactobacillus casei strain Shirota

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Immune System Stimulation by Probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Class II antimicrobial peptides from lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Purification and characterization of a bacteriocin produced by Lactobacillus acidophilus IBB 801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Bacteriocins: safe, natural antimicrobials for food preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial substance from a human Lactobacillus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Detection of a Lactobacillus substance that inhibits Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

H pylori colocalises with MUC5AC in the human stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Bacteriocin production with Lactobacillus amylovorus DCE 471 is improved and stabilized by fed-batch fermentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Modeling growth and bacteriocin production by Lactobacillus amylovorus DCE 471 in response to temperature and pH values used for sourdough fermentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

A combined model to predict the functionality of the bacteriocin-producing Lactobacillus sakei strain CTC 494.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Inducible bacteriocin production in Lactobacillus is regulated by differential expression of the pln operons and by two antagonizing response regulators, the activity of which is enhanced upon phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Functional analysis of promoters involved in quorum sensing-based regulation of bacteriocin production in Lactobacillus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Regulation of bacteriocin production in Lactobacillus plantarum depends on a conserved promoter arrangement with consensus binding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Cross-talk between enteric pathogens and the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Intracellular pathogens and the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Structural and functional lesions in brush border of human polarized intestinal Caco-2/TC7 cells infected by members of the Afa/Dr diffusely adhering family of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus plantarum inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Experimental effects of Saccharomyces boulardii on diarrheal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Expression of binding of plasminogen, thrombospondin, vitronectin, and fibrinogen, and adhesive properties by Escherichia coli strains isolated from patients with colonic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Adhesive and hydrophobic properties of Escherichia coli from the rectal mucosa of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Review article: treatment of mild to moderate ulcerative colitis and pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics and inflammatory bowel disease: is there a scientific rationale?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics in inflamatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics in inflammatory bowel disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Variable response to probiotics in two models of experimental colitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics, Irritable Bowel Syndrome, and Inflammatory Bowel Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Probiotics and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Medical therapy for induction and maintenance of remission in pouchitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial peptides: current status and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

The therapeutic potential of host-defense antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial peptides: properties and applicability

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Antimicrobial Peptides in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Mode of action of membrane active antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Permeability barrier of the gram-negative bacterial outer membrane with special reference to nisin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Bacteriocins: mechanism of membrane insertion and pore formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Tight junction proteins1This review is dedicated to the memory of Thomas Kreis.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEMSRE.2004.01.003